ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Clin Pharmacol Biopharm,
  • DOI: 10.4172/2167-065X.1000179

Pharmacogenomics: The Scientific Basis of Rational Drug Development and Prescribing

Sonya Abraham1 and Hannah Jethwa2*
1Imperial Clinical Research Facility, Imperial College London, , London, UK
2London North West Healthcare NHS Trust, , London, UK
*Corresponding Author : Hannah Jethwa, London North West Healthcare NHS Trust, London, UK, Tel: 020 8967 5316, Email: hannahjethwa@nhs.net

Received Date: Oct 30, 2017 / Accepted Date: Nov 11, 2017 / Published Date: Nov 16, 2017

Abstract

“It is more important to know what sort of a patient has a disease than what sort of a disease a patient has” (Hippocrates 460 BC-370 BC).

The holy grail of drug discovery is to ensure that an individual responds positively to an investigational drug with minimal or no adverse events. This could then translate to newly discovered drugs being licenced for prescribing as safe and effective therapeutics. Pharmacogenomics may herald the technology for this aspiration to become reality.

Uniting the disciplines of pharmacology and genomics, pharmacogenomics provides a mechanism to understand and predict the response of an individual to a drug or group of drugs. This is based on the premise that an individual’s genotype affects the pharmacokinetics, pharmacodynamics and, ultimately, the individual’s their response to a drug.

This review will begin by reviewing the history of drug development and then proceed to discuss the use of pharmacogenomics in drug development through case studies in oncology, respiratory and vaccinology. It will then go on to discuss how pharmacogenomics presently influences prescribing practices and how this technology may have the potential to enhance patient safety when medicines are administered.

Keywords: Pharmacology; Genomics; Pharmacokinetics; Pharmacodynamics

Citation: Abraham S, Jethwa H (2017) Pharmacogenomics: The Scientific Basis of Rational Drug Development and Prescribing. Clin Pharmacol Biopharm 6:179. Doi: 10.4172/2167-065X.1000179

Copyright: © 2017 Abraham S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top